EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 38 / Numéro 4 (Avril 2022) Med Sci (Paris), 38 4 (2022) 366-373 Références
Open Access
Numéro
Med Sci (Paris)
Volume 38, Numéro 4, Avril 2022
Page(s) 366 - 373
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2022040
Publié en ligne 29 avril 2022
  1. Dema B, Charles N. Autoantibodies in SLE: Specificities. Isotypes and Receptors. Antibodies (Basel) 2016 ; 5 : 2. [Google Scholar]
  2. La Cava A.. Putting together the autoimmunity puzzle. J Clin Invest 2015 ; 125 : 2184–2186. [CrossRef] [PubMed] [Google Scholar]
  3. Neiman M, Hellstrom C, Just D, et al. Individual and stable autoantibody repertoires in healthy individuals. Autoimmunity 2019 ; 52 : 1–11. [CrossRef] [PubMed] [Google Scholar]
  4. Dema B, Charles N. Advances in mechanisms of systemic lupus erythematosus. Discov Med 2014 ; 17 : 247–255. [PubMed] [Google Scholar]
  5. Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers 2016 ; 2 : 16039. [CrossRef] [PubMed] [Google Scholar]
  6. Terrier B, Mouthon L. Lupus érythémateux systémique : traitements par anticorps monoclonaux et molécules recombinantes. Med Sci (Paris) 2013 ; 29 : 65–73. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  7. Lee DSW, Rojas OL, Gommerman JL. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat Rev Drug Discov 2021; 20 : 179–99. [CrossRef] [PubMed] [Google Scholar]
  8. Anders HJ, Saxena R, Zhao MH, et al. Lupus nephritis. Nat Rev Dis Primers 2020; 6 : 7. [CrossRef] [PubMed] [Google Scholar]
  9. Charles N. Autoimmunity, IgE and FcepsilonRI-bearing cells. Curr Opin Immunol 2021; 72 : 43–50. [CrossRef] [PubMed] [Google Scholar]
  10. Lamri Y, Vibhushan S, Pacreau E, et al. Basophils and IgE contribute to mixed connective tissue disease development. J Allergy Clin Immunol 2021; 147 : 1478–89 e11. [CrossRef] [PubMed] [Google Scholar]
  11. Pellefigues C, Dema B, Lamri Y, et al. Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs. Nat Commun 2018 ; 9 : 725. [CrossRef] [PubMed] [Google Scholar]
  12. Karasuyama H, Miyake K, Yoshikawa S, Yamanishi Y. Multifaceted roles of basophils in health and disease. J Allergy Clin Immunol 2018 ; 142 : 370–380. [CrossRef] [PubMed] [Google Scholar]
  13. Miyake K, Shibata S, Yoshikawa S, Karasuyama H. Basophils and their effector molecules in allergic disorders. Allergy 2021; 76 : 1693–706. [CrossRef] [PubMed] [Google Scholar]
  14. Pellefigues C, Mehta P, Chappell S, et al. Diverse innate stimuli activate basophils through pathways involving Syk and IkappaB kinases. Proc Natl Acad Sci USA 2021; 118 : e2019524118. [CrossRef] [PubMed] [Google Scholar]
  15. Charles N, Watford WT, Ramos HL, et al. Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity 2009 ; 30 : 533–543. [CrossRef] [PubMed] [Google Scholar]
  16. Denzel A, Maus UA, Rodriguez Gomez M, et al. Basophils enhance immunological memory responses. Nat Immunol 2008 ; 9 : 733–742. [CrossRef] [PubMed] [Google Scholar]
  17. Charles N, Hardwick D, Daugas E, et al. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 2010 ; 16 : 701–707. [CrossRef] [PubMed] [Google Scholar]
  18. Rodriguez Gomez M, Talke Y, Goebel N, et al. Basophils support the survival of plasma cells in mice. J Immunol 2010; 185 : 7180–5. [CrossRef] [PubMed] [Google Scholar]
  19. Otsuka A, Nakajima S, Kubo M, et al. Basophils are required for the induction of Th2 immunity to haptens and peptide antigens. Nat Commun 2013 ; 4 : 1739. [CrossRef] [PubMed] [Google Scholar]
  20. Camussi G, Tetta C, Benveniste J. Detection of basophil sensitization by IgE antibodies to nuclear antigens in connective tissue diseases. Int Arch Allergy Appl Immunol 1982 ; 69 : 358–362. [CrossRef] [Google Scholar]
  21. Pan Q, Gong L, Xiao H, et al. Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus. Front Immunol 2017 ; 8 : 348. [PubMed] [Google Scholar]
  22. Dema B, Pellefigues C, Hasni S, et al. Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PloS one 2014 ; 9 : e90424. [CrossRef] [PubMed] [Google Scholar]
  23. Lamri Y, Charles N. IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target. Antibodies (Basel) 2020; 9. [Google Scholar]
  24. Dema B, Charles N, Pellefigues C, et al. Immunoglobulin E plays an immunoregulatory role in lupus. J Exp Med 2014 ; 211 : 2159–2168. [CrossRef] [PubMed] [Google Scholar]
  25. Halfon M, Bachelet D, Hanouna G, et al. CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritis. Nephrol Dial Transplant 2021; 12 : 2256–62. [CrossRef] [PubMed] [Google Scholar]
  26. Oon S, Monaghan K, Ng M, et al. A potential association between IL-3 and type I and III interferons in systemic lupus erythematosus. Clin Transl Immunology 2019 ; 8 : e01097. [PubMed] [Google Scholar]
  27. Renner K, Hermann FJ, Schmidbauer K, et al. IL-3 contributes to development of lupus nephritis in MRL/lpr mice. Kidney Int 2015 ; 88 : 1088–1098. [CrossRef] [PubMed] [Google Scholar]
  28. Dema B, Lamri Y, Pellefigues C, et al. Basophils contribute to pristane-induced Lupus-like nephritis model. Sci Rep 2017 ; 7 : 7969. [CrossRef] [PubMed] [Google Scholar]
  29. Henault J, Riggs JM, Karnell JL, et al. Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol 2016 ; 17 : 196–203. [CrossRef] [PubMed] [Google Scholar]
  30. Sapkota B, Al Khalili Y. Mixed Connective Tissue Disease. StatPearls. Treasure Island (FL)2021. [Google Scholar]
  31. Greidinger EL, Zang Y, Jaimes K, et al. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum 2006 ; 54 : 661–669. [CrossRef] [PubMed] [Google Scholar]
  32. Greidinger EL, Zang YJ, Jaimes K, et al. CD4+ T cells target epitopes residing within the RNA-binding domain of the U1–70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease. J Immunol 2008 ; 180 : 8444–8454. [CrossRef] [PubMed] [Google Scholar]
  33. Leyva-Castillo JM, Hener P, Michea P, et al. Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade. Nat Commun 2013 ; 4 : 2847. [CrossRef] [PubMed] [Google Scholar]
  34. Musio S, Costanza M, Poliani PL, et al. Treatment with anti-FcepsilonRIalpha antibody exacerbates EAE and T-cell immunity against myelin. Neurol Neuroimmunol Neuroinflamm 2017 ; 4 : e342. [CrossRef] [PubMed] [Google Scholar]
  35. Pellefigues C, Naidoo K, Mehta P, et al. Basophils promote barrier dysfunction and resolution in the atopic skin. J Allergy Clin Immunol 2021; 148 : 799–812 e10. [CrossRef] [PubMed] [Google Scholar]
  36. Hasni S, Gupta S, Davis M, et al. Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus. Arthritis Rheumatol 2019 ; 71 : 1135–1140. [CrossRef] [PubMed] [Google Scholar]
  37. Maurer M, Gimenez-Arnau AM, Sussman G, et al. Ligelizumab for Chronic Spontaneous Urticaria. N Engl J Med 2019 ; 381 : 1321–1332. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.